A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction
Titel:
A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction
Auteur:
Cantarovich, M Ross, H Arizon, J Orus, J Straatman, L Howlett, J Lage, E Crespo, M Wang, S Haddad, H Pulpon, L Andres, I Hauck, W
Verschenen in:
The journal of heart and lung transplantation
Paginering:
Jaargang 23 (2004) nr. 2S pagina's 1 p.
Jaar:
2004
Inhoud:
Uitgever:
International Society for Heart and Lung Transplantation